ACQUIRED · 2018
Who Acquired GENEWIZ?
Azenta, Inc. · $450.0M· 16.9× EBITDA
The acquisition
GENEWIZ was acquired by Azenta, Inc. in 2018 for $450.0M. The deal was priced at 16.9× EBITDA / 3.60× revenue.
GENEWIZ at time of acquisition
Revenue
$124.1M
EBITDA
$26.6M
Deal value
$450.0M
EV / EBITDA
16.9×
Other acquisitions by Azenta, Inc.
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- RURO, Inc. · 2020 · $15.2M
Similar laboratory services acquisitions
- GeneSeek (Neogen Animal Genomics) · acquired by Zoetis in 2026 · $160.0M
- CHS Outreach Laboratory Assets · acquired by Laboratory Corporation of America Holdings in 2025 · $194.5M
- OPKO / BioReference Health (Clinical Diagnostics Business) · acquired by Labcorp in 2025 · $192.5M
- Akoya Biosciences, Inc. · acquired by Quanterix Corporation in 2025 · $286.0M
- Enzo Biochem, Inc. · acquired by Battery Ventures in 2025 · $37.0M
Run a valuation for a similar laboratory services business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the laboratory services calculator →More on laboratory services valuations
- Laboratory Services valuation calculator· head-term variant
- Laboratory Services median multiples· real-deal benchmarks
- How to value a laboratory services· long-form guide
Sourced from Bond rating releases and SEC filings. Full deal page.
Citation: ExitValue.ai. (2018). GENEWIZ acquired by Azenta, Inc.. https://exitvalue.ai/acquired/genewiz